Pujan Sasmal

Employment

Employment history is unavailable.

Education

• National Institute of Pharmaceutical Education and Research Ph.D.
  2022 - Present
• Acharya and BM Reddy College of Pharmacy Master of Pharmacy
  2020 - 2022

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Lewis Acid Catalyzed Dual Strain-Release Platform for Transforming Azabicyclo[1.1.0]butanes into Functionalized Azetidines with Donor–Acceptor(D-A) Cyclopropanes and Bicyclo[1.1.0]butanes
  Subhadeep Hazra, Manveer Patel, Soumik Mondal

  +4 more

  • Rezwan Ahmed
  • Pujan Sasmal
  • Swati De
  • Jaideep Saha
  Organic Letters 2026 DOI: 10.1021/acs.orglett.6c00880
  +Save
• HFIP-Promoted Strain-Release-Driven Functionalization of Azabicyclo[1.1.0]butanes with Heterocyclobutane Trichloroacetimidates
  Pujan Sasmal, Subhadeep Hazra, Thakar Neha Rajendra +3 more
  Organic Letters 2026 DOI: 10.1021/acs.orglett.6c00290
  +Save
• Enhancing understanding of phytochemicals’ role in managing metabolic disorders
  Plant-Based Drug Discovery 2026 DOI: 10.1016/b978-0-443-31698-2.00002-3
  +Save
• Merging strain-release functionalization with ortho-quinone-methide (o-QM): modular access to N-functionalized azetidines
  Pujan Sasmal, Aaron Taites, Rahul Jain +1 more
  Organic Chemistry Frontiers 2026 DOI: 10.1039/D6QO00953K
  +Save
• Beyond peptides: Unveiling the design strategies, structure activity correlations and protein-ligand interactions of small molecule inhibitors against PD-1/PD-L1
  Pujan Sasmal, P. Prabitha, B. R. Prashantha Kumar +3 more
  Bioorganic Chemistry 2025 DOI: 10.1016/j.bioorg.2024.108036
  +Save
• Design and Discovery of Lophine Derivatives as Multi-Targeting Agents by Molecular Docking, ADMET, MD Simulation and Pharmacophore Analysis: A Computational Approach
  Pujan Sasmal, Shyamal Kumar Biswas, Akash Koley

  +2 more

  • Rimpa Jana
  • Jagrity Biswas
  Turkish Computational and Theoretical Chemistry 2025 DOI: 10.33435/tcandtc.1531766
  +Save
• Aza-ortho-Quinone Methide Promoted Strain-Release-Driven Conversion of Azabicyclo[1.1.0]butanes into Functionalized Azetidines
  Bandana Singh, Pujan Sasmal, Aaron Taites

  +2 more

  • Subhadeep Hazra
  • Jaideep Saha
  Organic Letters 2024 DOI: 10.1021/acs.orglett.4c03577
  +Save
• Biological evaluation of Ficus elastica leaves for antidepressant and anxiolytic activity
  Akash Koley, Shyamal Kumar Biswas, Nabanita Sadhukhan

  +2 more

  • Souvik Ghosh
  • Pujan Sasmal
  Drug Discovery 2023 DOI: 10.54905/disssi.v17i39.e21dd1924
  +Save
• Computational analysis of natural product B-Raf inhibitors
  Sumiran Chettri, Pujan Sasmal, Tenzin Adon +3 more
  Journal of Molecular Graphics and Modelling 2023 DOI: 10.1016/j.jmgm.2022.108340
  +Save
• Designing Studies in Pharmaceutical and Medicinal Chemistry
  Nulgumnalli Manjunathaiah Raghavendra, B. R. Prashantha Kumar, Pujan Sasmal +4 more
  Quintessence of Basic and Clinical Research and Scientific Publishing 2023 DOI: 10.1007/978-981-99-1284-1_9
  +Save
• COMPUTATIONAL VALIDATION OF NATURAL PRODUCT B-RAF INHIBITORS FOR THE TREATMENT OF MELANOMA
  NIPER PHARMACON 2022, “International Symposium on Recent Trends and Future Opportunities in Pharmaceuticals” 2022 DOI: 10.13140/RG.2.2.18170.98246
  +Save
• IMMUNOINHIBITORY CHECKPOINT PROTEINS AND THEIR ROLE IN CARCINOGENESIS
  2nd International Conference on Transforming Ripples in Healthcare Research: Obstacles, Sustenance & Cutting-edge Innovations (ICTRHR-2022) 2022 DOI: 10.13140/RG.2.2.15813.32481/1
  +Save
• Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction
  Pujan Sasmal, Sajeev Kumar Babasahib, B. R. Prashantha Kumar +1 more
  Bioorganic and Medicinal Chemistry 2022 DOI: 10.1016/j.bmc.2022.117001
  +Save
• Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer
  Prasad Sanjay Dhiwar, Gurubasavaraja Swamy Purawarga Matada, Nulgumnalli Manjunathaiah Raghavendra +6 more
  Medicinal Chemistry Research 2022 DOI: 10.1007/s00044-022-02934-7
  +Save